Clincosm LogoSign in Get a demo

VELHOR: Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler

Sponsor
University Hospital, Brest (Other)
Overall Status
Completed
CT.gov ID
NCT03360162
Collaborator
(none)
46
Enrollment
1
Location
1.2
Actual Duration (Months)
36.8
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The use of ultrasonography in detecting giant cell arteritis ( GCA) is emerging. Currently, temporal biopsy is the gold standard to diagnose GCA but studies have shown the interest to use B mode ultrasonography. However, until now, the study of velocities in GCA have not been yet performed.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    46 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler
    Actual Study Start Date :
    Nov 2, 2017
    Actual Primary Completion Date :
    Dec 10, 2017
    Actual Study Completion Date :
    Dec 10, 2017

    Outcome Measures

    Primary Outcome Measures

    1. Velocimetric Study of Temporal Arteries in Patients With Horton Disease Using Scan-Doppler [2 months]

      velocimetric temporal arterial study in giant arteritis

    Secondary Outcome Measures

    1. evaluation of the halo sign in giant arteritis using B mode ultrasonography [2 months]

      presence or absence of the halo sign in giant arteritis patients

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    55 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • patients with suspicious giant arteritis
    Exclusion Criteria:
    • patients who have already been treated or diagnosed for giant arteritis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHRU de Brest Brest France 29609

    Sponsors and Collaborators

    • University Hospital, Brest

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Brest
    ClinicalTrials.gov Identifier:
    NCT03360162
    Other Study ID Numbers:
    • VELHOR ( 29BRC17.0227)
    First Posted:
    Dec 4, 2017
    Last Update Posted:
    Apr 21, 2020
    Last Verified:
    Apr 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Polymyalgia Rheumatica
    Giant Cell Arteritis

    Study Results

    No Results Posted as of Apr 21, 2020